ESTROGENICITY OF ESSENTIAL OILS IS NOT REQUIRED TO RELIEVE SYMPTOMS OF UROGENITAL ATROPHY IN BREAST CANCER SURVIVORS

Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors

Background Urogenital atrophy (UA) is a common treatment-limiting side effect of endocrine therapies.Topical estrogen is effective Dog Treats but systemic absorption may counter aromatase inhibitor efficacy.Numerous complementary approaches are marketed for use in UA without rigorous testing of their estrogenicity.We tested multiple essential oils

read more